Argyrophilic grain disease (AGD) is a progressive degenerative disease of the human brain, the prevalence of which increases with advancing age. The features of AGD in autopsied brains from 32 centenarians were studied using phosphorylated tau (AT8) immunostaining combined with Gallyas-Braak staining and 4R tau-specific antibody (RD4) immunostaining. Ten of 32 centenarians were diagnosed as AGD, yielding an overall frequency of 31.3%. In the demented group, nine (39.1%) of 23 cases were found with argyrophilic grains (AGs), while in the non-demented group, AGs were found in only one (11.1%) of nine cases, the difference between them being significant (P<0.05). Among the cases with Alzheimer's disease (AD), five (41.7%) of 12 were found with AGs. One (25%) of four cases with senile dementia with tangles (SDT) also suffered from AGD. Dementia caused by "pure" AGD accounted for 13% (3/23) among demented subjects. Our findings indicated that there is a high frequency of AGD in centenarians. In agreement with previous studies, we favor the view that age may be one of the risk factors for AGD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00401-006-0043-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Current Progress and Future Directions in Non-Alzheimer's Disease Tau PET Tracers.
ACS Chem Neurosci
January 2025
Research Center for Accelerator and Radioisotope Science, Tohoku University, Sendai, Miyagi 980-0845, Japan.
Alzheimer's disease (AD) and non-AD tauopathies are dominant public health issues driven by several factors, especially in the aging population. The discovery of first-generation radiotracers, including [F]FDDNP, [C]PBB3, [F]flortaucipir, and the [F]THK series, for the in vivo detection of tauopathies has marked a significant breakthrough in the fields of neuroscience and radiopharmaceuticals, creating a robust new category of labeled compounds: tau positron emission tomography (PET) tracers. Subsequently, other tau PET tracers with improved binding properties have been developed using various chemical scaffolds to target the three-repeat/four-repeat (3R/4R) tau folds in AD.
View Article and Find Full Text PDFLATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy.
Continuum (Minneap Minn)
December 2024
Article Synopsis
- Alzheimer’s disease (AD) is the most common cause of dementia, but there are other conditions like LATE (limbic-predominant age-related TDP-43 encephalopathy) that also produce similar symptoms, particularly in older adults.
- Recent research shows that LATE can coexist with AD and may occur in individuals with cognitive impairment, leading to difficulty in clinical diagnosis due to the lack of direct biomarkers for TDP-43 pathology.
- Understanding and recognizing non-AD conditions like LATE and primary age-related tauopathy is crucial for neurologists, especially for patients over 75 experiencing slow cognitive decline.
Article Synopsis
- - The emergence of neuropsychiatric symptoms in middle-aged individuals poses diagnostic challenges, making it tough to distinguish between primary psychiatric disorders and early neurodegenerative diseases, especially when brain imaging shows no clear abnormalities.
- - A case study of a 59-year-old woman showed initial symptoms similar to a mood disorder and behavioral frontotemporal dementia, but autopsy revealed a mix of Lewy body disease and tau-related changes.
- - This case highlights the complexities of diagnosing late-onset neuropsychiatric symptoms, underlines their connection to dementia, and stresses the importance of accurate diagnosis for developing targeted therapies and improving clinical trial participation.
Neuropathological Heterogeneity of Dementia Due to Combined Pathology in Aged Patients: Clinicopathological Findings in the Vallecas Alzheimer's Reina Sofía Cohort.
J Clin Med
November 2024
Reina Sofía Alzheimer Center, CIEN Foundation, ISCIII, 28031 Madrid, Spain.
Article Synopsis
- Recent research on late-life dementia highlights both neurodegenerative and vascular conditions contributing to the varied symptoms in patients, utilizing the Vallecas Alzheimer's Reina Sofía (VARS) cohort with over 550 participants and associated brain donations.
- The study focused on 167 patients, primarily older women (79%) with an average age of 88, and found a significant presence of the ApoE-e4 gene variant (43%).
- The main findings revealed that 79.6% had Alzheimer's disease, with a high prevalence of other conditions like vascular dementia and Lewy body dementia, and over 71.1% of the patients showed multiple neuropathological findings, indicating the complexity of dementia in this cohort.
Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series.
Lancet Neurol
December 2024
Neurological Tissue Bank of the Biobank, FRCB-IDIBAPS, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Department of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Article Synopsis
- The study examines post-mortem brain tissues from individuals diagnosed with idiopathic REM sleep behavior disorder (IRBD) to investigate its potential link to neurodegenerative diseases, specifically focusing on signs of neuronal loss and the presence of key protein deposits.
- Researchers analyzed samples from 20 participants, most of whom were diagnosed with Lewy body disease, while a small number had Parkinson's disease-related conditions, revealing significant findings of neuronal damage associated with α-synuclein proteins, particularly in brain regions controlling REM sleep.
- While the sample size limited the statistical analysis, the outcomes suggest a strong correlation between IRBD and neurodegenerative diseases, emphasizing the importance of these pathological features for understanding the progression
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!